Edition:
United Kingdom

Nektar Therapeutics (NKTR.OQ)

NKTR.OQ on NASDAQ Stock Exchange Global Select Market

41.69USD
15 Feb 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$41.69
Open
$43.15
Day's High
$43.28
Day's Low
$40.05
Volume
876,591
Avg. Vol
780,539
52-wk High
$111.36
52-wk Low
$29.26

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.49 December 19 Feb 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 5 5 5 4
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.82 1.82 1.82 1.80

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 7 56.27 192.40 20.55 49.02
Quarter Ending Jun-19 7 50.44 145.90 21.75 50.85
Year Ending Dec-19 10 244.62 637.80 82.30 233.75
Earnings (per share)
Quarter Ending Mar-19 7 -0.49 0.49 -0.77 -0.35
Quarter Ending Jun-19 7 -0.52 0.23 -0.72 -0.35
Year Ending Dec-19 9 -2.00 1.21 -3.08 -1.04

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 26.08 27.76 1.68 6.44
Quarter Ending Jun-18 1,033.34 1,087.72 54.38 5.26
Quarter Ending Mar-18 35.62 38.02 2.40 6.75
Quarter Ending Dec-17 36.98 95.47 58.49 158.18
Quarter Ending Sep-17 117.32 152.93 35.61 30.35
Earnings (per share)
Quarter Ending Sep-18 -0.63 -0.56 0.07 -10.94
Quarter Ending Jun-18 5.22 5.33 0.11 2.07
Quarter Ending Mar-18 -0.54 -0.60 0.06 -10.29
Quarter Ending Dec-17 -0.35 -0.11 0.24 -68.81
Quarter Ending Sep-17 0.18 0.37 0.19 102.74

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 56.27 56.27 56.27 56.27 49.02
Quarter Ending Jun-19 50.44 50.44 50.44 50.44 50.85
Year Ending Dec-19 244.62 244.62 244.62 250.12 233.75
Earnings (per share)
Quarter Ending Mar-19 -0.49 -0.49 -0.49 -0.49 -0.35
Quarter Ending Jun-19 -0.52 -0.52 -0.52 -0.52 -0.35
Year Ending Dec-19 -2.00 -2.00 -2.00 -1.89 -1.04

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 0 0
Quarter Ending Jun-19 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings
Quarter Ending Mar-19 0 0 0 0
Quarter Ending Jun-19 0 0 0 0
Year Ending Dec-19 0 0 0 0